Heart rate reduction as a marker to optimize carvedilol treatment and enhance myocardial recovery in pediatric dilated cardiomyopathy
Conclusion: This study demonstrates that HRR is safe and improvement in LVEF is related to the degree of HRR. The magnitude of LVEF improvement was enhanced by a major reduction in HR. It provides evidence that HRR could be used as a clinical marker to treat HF in children.
Source: Frontiers in Physiology - Category: Physiology Source Type: research
More News: Cardiology | Cardiomyopathy | Children | Coreg | Dilated Cardiomyopathy | Heart | Heart Transplant | Pediatrics | Physiology | Study | Transplant Surgery | Transplants